Zobrazeno 1 - 10
of 2 773
pro vyhledávání: '"Costa, LJ"'
Autor:
Arnold KD; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Ong KL; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Ravi G; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Cutshall H; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA., Purnell K; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Wessel MC; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Godby KN; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Bal S; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Giri S; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Rogers LQ; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Division of Preventive Medicine, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Demark-Wahnefried W; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Davies FE; Perlmutter Comprehensive Cancer Center, Langone Medical Center, New York University, New York, NY, 10021, USA., Costa LJ; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Morgan GJ; Perlmutter Comprehensive Cancer Center, Langone Medical Center, New York University, New York, NY, 10021, USA., Birmann BM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA., Brown EE; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. elizabethbrown@uabmc.edu.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. elizabethbrown@uabmc.edu.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Jul; Vol. 131 (2), pp. 312-324. Date of Electronic Publication: 2024 Jun 07.
Autor:
Ravi G; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Bal S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Joiner L; Department of Pharmacy, University of Alabama at Birmingham, Birmingham, Alabama, USA., Giri S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Sentell M; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Hill T; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA., Godby KN; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Costa LJ; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1300-1306. Date of Electronic Publication: 2024 Jan 30.
Autor:
Bal S; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Costa LJ; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Feb; Vol. 204 (2), pp. 449-454. Date of Electronic Publication: 2023 Nov 30.
Autor:
Epperla N; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.; Division of Hematology and Hematologic Malignancies, Department of Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Huang Y; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Cashen AF; Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO., Vaughn JL; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.; Department of Medicine, Smilow Cancer Hospital, Yale New Haven, New Haven, CT., Hanel W; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Badar T; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Department of Medicine, Mayo Clinic, Jacksonville, FL., Barta SK; Department of Medicine, Fox Chase Cancer Center, Philadelphia, PA.; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Caimi PF; Department of Medicine, Case Western Reserve, Cleveland, OH.; Department of Medicine, Cleveland Clinic, Cleveland, OH., Sethi TK; Department of Medicine, Smilow Cancer Hospital, Yale New Haven, New Haven, CT.; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Reddy N; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Karmali R; Department of Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, IL., Bello C; Department of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL., Chavez JC; Department of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL., Kothari SK; Department of Medicine, Smilow Cancer Hospital, Yale New Haven, New Haven, CT.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Svoboda J; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Lansigan F; Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Glenn MJ; Division of Hematology and Hematologic Malignancies, Department of Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Cohen JB; Department of Medicine, Winship Cancer Institute, Emory University, Atlanta, GA., Sorge C; Department of Medicine, University of Kentucky, Lexington, KY., Christian B; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Herrera AF; Department of Medicine, City of Hope National Medical Center, Duarte, CA., Hamadani M; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Costa LJ; Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL., Xavier AC; Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL.
Publikováno v:
Blood advances [Blood Adv] 2024 Nov 12; Vol. 8 (21), pp. 5458-5466.
Autor:
Gahagan A; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, AL, USA., Maheshwari S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Rangarajan S; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, AL, USA., Ubersax C; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Tucker A; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Harmon C; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Pasala MS; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Bal S; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, AL, USA., Godby K; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, AL, USA., Ravi G; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, AL, USA., Costa LJ; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, AL, USA., Williams GR; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA., Giri S; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, AL, USA; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: smithgiri@uabmc.edu.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2024 Nov; Vol. 15 (8), pp. 102051. Date of Electronic Publication: 2024 Sep 05.
Autor:
Kidwell K; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Bal S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Godby K; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Ravi G; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Costa LJ; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Shrestha S; Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama., Salzman D; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Hayes T; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Williams GR; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama., Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama., Giri S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama; Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: smithgiri@uabmc.edu.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1086.e1-1086.e7. Date of Electronic Publication: 2024 Jun 12.
Autor:
Voorhees PM; Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC, USA., Sborov DW; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Laubach J; Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA, USA., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Reeves B; Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC, USA., Rodriguez C; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Silbermann R; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Costa LJ; University of Alabama at Birmingham Hospital, Birmingham, AL, USA., Anderson LD; Myeloma, Waldenstrom's & Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Nathwani N; Judy & Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Shah N; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Efebera YA; OhioHealth, Blood & Marrow Transplant, Columbus, OH, USA., Holstein SA; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Costello C; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA., Wildes TM; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Cowan AJ; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Dinner S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Gries KS; Janssen Research & Development, LLC, Raritan, NJ, USA., Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA., Cortoos A; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USA., Patel S; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USA., Lin TS; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USA., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Richardson PG; Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Oct 25, pp. 1-25. Date of Electronic Publication: 2024 Oct 25.
Autor:
David SC, Schaub A, Terrettaz C, Motos G, Costa LJ, Nolan DS, Augugliaro M, Wynn HK, Glas I, Pohl MO, Klein LK, Luo B, Bluvshtein N, Violaki K, Hugentobler W, Krieger UK, Peter T, Stertz S, Nenes A, Kohn T
Publikováno v:
Journal of virology [J Virol] 2024 Oct 22; Vol. 98 (10), pp. e0122224. Date of Electronic Publication: 2024 Sep 19.
Autor:
Pelajo-Machado M; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil., da Silva ADS; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil., Rodrigues DDRF; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil., Paiva MB; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil., Muller R; Fundação Oswaldo Cruz-Fiocruz, Bio-Manguinhos, Vice-Diretoria de Inovação, Departamento Experimental e Pré-Clínico, Laboratório de Ensaios Pré-Clínicos, Rio de Janeiro, RJ, Brasil., da Costa LJ; Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Virologia, Laboratório de Genética e Imunologia das Infecções Virais, Rio de Janeiro, RJ, Brasil., Manso PPA; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil., Dos Santos JPR; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Medicina Experimental e Saúde, Rio de Janeiro, RJ, Brasil., da Silva ESRF; Fundação Oswaldo Cruz-Fiocruz, Central Analítica COVID-19, Rio de Janeiro, RJ, Brasil., Alves ADR; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil., Oliveira JM; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil., Pinto MA; Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil.
Publikováno v:
Memorias do Instituto Oswaldo Cruz [Mem Inst Oswaldo Cruz] 2024 Oct 21; Vol. 119, pp. e240100. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).
Autor:
van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. n.vandedonk@amsterdamumc.nl., Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Costa LJ; University of Alabama at Birmingham, Birmingham, AL, USA., Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain., Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Perrot A; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Garfall AL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Thaman P; Janssen Research & Development, Bridgewater, NJ, USA., Qi K; Janssen Research & Development, Titusville, NJ, USA., Uhlar C; Janssen Research & Development, Spring House, PA, USA., Chastain K; Janssen Research & Development, Raritan, NJ, USA., Doyle M; Janssen Sciences Ireland, Dublin, Ireland., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Oct 21; Vol. 14 (1), pp. 186. Date of Electronic Publication: 2024 Oct 21.